Cargando…
Predictors of Survival in Esophageal Squamous Cell Carcinoma with Pathologic Major Response after Neoadjuvant Chemoradiation Therapy and Surgery: The Impact of Chemotherapy Protocols
Tumor recurrence is an important problem threatening esophageal cancer patients after surgery, even when they achieve a pathologic major response (pMR) after neoadjuvant concurrent chemoradiation therapy (CCRT). The predictors related to overall survival and disease progression for these patients re...
Autores principales: | Li, Chia-Ying, Huang, Pei-Ming, Chu, Pei-Yi, Chen, Po-Ming, Lin, Mong-Wei, Kuo, Shuenn-Wen, Lee, Jang-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061941/ https://www.ncbi.nlm.nih.gov/pubmed/27777949 http://dx.doi.org/10.1155/2016/6423297 |
Ejemplares similares
-
Prognostication and optimal criteria of circumferential margin involvement for esophageal cancer after chemoradiation and esophagectomy
por: Potdar, Ankit, et al.
Publicado: (2023) -
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant Chemoradiation
por: Hsu, Feng-Ming, et al.
Publicado: (2015) -
Clinical significance of risk stratification of esophageal squamous cell carcinoma after neoadjuvant chemoradiation and surgery
por: Wu, Ya-hua, et al.
Publicado: (2021) -
Selection of minimally invasive surgical approaches for treating esophageal cancer
por: Lee, Yu‐Kwang, et al.
Publicado: (2022) -
Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)